FIMM Metabolomics User Policy

User policy.

Core facility is open to both academic and commercial users nationally and internationally on primary access model being first come, first served. 



The use of HiLIFE LSRIs should be mentioned in the acknowledgement section of publications, for example with the sentence “The facilities and expertise of FIMM Metabolomics, supported by HiLIFE is gratefully acknowledged”. When LSRI PI or personnel provides substantial intellectual input to the project, they should be included as authors according to established international guidelines.

Our research is funded by: